Cresco Labs Inc. (CL.CN)
| Previous Close | 10.86 |
| Open | 11.34 |
| Bid | 11.16 x 0 |
| Ask | 11.19 x 0 |
| Day's Range | 10.93 - 11.34 |
| 52 Week Range | 7.45 - 22.20 |
| Volume | 107,613 |
| Avg. Volume | 253,568 |
| Market Cap | 2.994B |
| Beta (5Y Monthly) | 2.06 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.29 |
| Earnings Date | Nov. 16, 2021 - Nov. 22, 2021 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Market Exclusive
Cannabis Sector Weekly Roundup
BioHarvest Sciences Inc., Icanic Brands Co Inc. & Cann Group Ltd. Among Top Cannabis Gainers For The Week. TerrAscend Corp & Columbia Care Inc Made the Headlines with Positive News. Key Developments to Note in the Proceedings of the Federal Legalization of Marijuana With State cannabis legalization ramping up across the U.S. and chances of […] The post Cannabis Sector Weekly Roundup appeared first on Market Exclusive.
- Business Wire
Cresco Labs Closes Acquisition of Cultivate, Strengthens Position in Massachusetts
CHICAGO, September 03, 2021--CRESCO LABS CLOSES ACQUISITION OF CULTIVATE, STRENGTHENS POSITION IN MASSACHUSETTS
- GlobeNewswire
BriaCell Therapeutics Appoints Marc Lustig to its Board of Directors
BERKELEY, Calif. and VANCOUVER, British Columbia, Sept. 01, 2021 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX-V: BCT) (“BriaCell” or the “Company”), a clinical-stage biotechnology company specializing in targeted immunotherapies for advanced breast cancer, announces the appointment of Mr. Marc Lustig to the Company's Board of Directors, effective September 1, 2021. Marc, through his investment company L5 Capital Inc., owns 1,530,000 common shares of BriaCell, repres
